23d • General discussion
Inside the FDA's New Peptide Review: What PCAC Will Decide Next
Behind the scenes of the FDA's recent peptide reversal, a powerful but little-known committee is preparing to make the final call. The Pharmacy Compounding Advisory Committee (PCAC) — a panel of experts that advises the FDA on which substances can be legally compounded is now tasked with reviewing 12 peptides previously locked in the restrictive "Category 2 – Do Not Compound" list.
The stakes couldn't be higher. If PCAC votes in favor of removal, peptides like BPC-157, GHK-Cu, and MOTS-c could soon be available through regulated compounding pharmacies. If not, the underground research market will remain the only option for millions of researchers and biohackers.
What Is PCAC and Why Does It Matter?
The Pharmacy Compounding Advisory Committee may not be widely known, but within the peptide industry, it holds the utmost significance. This committee advises the FDA on:
- Which substances present "demonstrable difficulties" for compounding
- Which drugs should be added to or removed from the "Do Not Compound" list
- Safety and efficacy data for bulk drug substances
In short: PCAC decides what pharmacists can and cannot make for patients.
For years, the committee took a hardline stance on peptides, lumping them into the high-risk category. But now, under pressure from HHS Secretary Robert F. Kennedy Jr. and with public backing from figures like Donald Trump Jr. , the committee is reopening the debate.
The 12 Peptides Under Review
PCAC is currently evaluating a diverse range of research areas for the compounds. BPC-157 is studied for tissue repair and gut healing. TB-500 focuses on regeneration and recovery. Semaglutide and retatrutide are key players in GLP-1 and triple-agonist metabolic research. MOTS-c is at the forefront of mitochondrial ageing studies, while Epithalon is known for telomere longevity research.
GHK-Cu is widely used for connective tissue and copper-related studies. Thymosin Alpha-1 supports immune modulation research. PT-141 is studied in the melanocortin space. Selank and Semax are cognitive and neuroplasticity-focused compounds, and CJC-1295 is a well-known growth hormone secretagogue.
What PCAC Will Consider
According to sources familiar with the process, PCAC will evaluate three key factors for each peptide:
- Scientific evidence – Is there legitimate research supporting the peptide's use?
- Safety profile – Does the peptide present unacceptable risks when compounded?
- Clinical need – Is there a demonstrated demand from researchers and physicians?
Insiders suggest that BPC-157, GHK-Cu, and MOTS-c have the strongest cases, thanks to decades of published research and growing clinical interest.
The Biohacking Community Weighs In
Inside the Biohacking & Longevity Group on Skool , members are already preparing for both outcomes. One moderator wrote:
"If PCAC votes yes, we get regulated access, verified quality, and medical oversight. If they vote no, nothing changes — but we lose a once-in-a-decade opportunity to legitimize this space."
Others are more optimistic: "RFK Jr. is pushing hard. Trump Jr. is amplifying. The momentum is undeniable. PCAC would be foolish to ignore it."
Where to Source Peptides During the Review
While PCAC deliberates, researchers and biohackers still need reliable, high-purity compounds. That's where Orion Peptides comes in. They offer:
- 99%+ purity verified by independent third-party labs
- Same-day shipping on orders before 3 PM PST
- Free shipping on orders over $200
Whether you're studying BPC-157 for gut integrity, GHK-Cu for tissue remodeling, or MOTS-c for mitochondrial function, Orion Peptides delivers research-grade quality. Use the Orion 10 coupon code at checkout to save.
What's Next?
PCAC is expected to issue a preliminary recommendation within 60 days, with a final FDA decision following shortly after. Until then, the peptide world holds its breath.
One thing is certain: the debate is no longer about if peptides have value, but how to regulate them safely and effectively.
👉 Join the discussion: Biohacking & Longevity Group👉 Get research-grade peptides: Orion Peptides – use code ORION10
Disclaimer: All products sold by Orion Peptides are for laboratory and research use only. Not for human consumption.
0
0 comments
Inside the FDA's New Peptide Review: What PCAC Will Decide Next
powered by
skool.com/biohacking-and-longevity-group-3757
All-in-one peptide education community. 🧪
Dosing guides, storage protocols, stacking frameworks, vendor intel, GLP-1 research, and expert support.🧬
Suggested communities
Powered by